EN
HI
Zydus Lifesciences Chart
Zydus Lifesciences Share Key Metrics
Volume
19.77 L
Market Cap
112829.02 CR
LTQ@LTP
1@1121.30
ATP
1118.25
Var Margin
12.9 %
Circuit Range
991.3-1211.5
Delivery %
57.18 %
Value
221.07 CR
ASM/GSM
No
Market Lot
1
Summary
Zydus Lifesciences share price is ₹1121.3 as of 29 Jun, 2026. The stock Zydus Lifesciences intraday movement has stayed between ₹1099.00 and ₹1125.30, while on a 52-week basis,Zydus Lifesciences price 52 week high is ₹1126.00 & its 52 week low is ₹835.50.
In terms of trading activity, Zydus Lifesciences has recorded a volume of 1976891 shares, The Zydus Lifesciences has a market cap of ₹1006233990 CR. The stock’s Average Traded Price (ATP) stands at ₹1118.25, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1121.30.
Zydus Lifesciences operates within a circuit range of ₹991.30 – ₹1211.50, with a Value of ₹221.07 CR. The Delivery Percentage for the day is 57.18%. Additionally, Zydus Lifesciences currently falls under the No framework, and trades with a market lot size of 1.
Zydus Lifesciences Fundamentals
P/E Ratio
21.8
P/B Ratio
4.22
Div. Yield
0.09
Sector P/E
69.63
Sector P/B
3.12
Sec. Div. Yield
0.53
Zydus Lifesciences Resistance and Support
Pivot 1103.67
Resistance
First Resistance
1111.04
Second Resistance
1120.67
Third Resistance
1128.04
Support
First Support
1094.04
Second Support
1086.67
Third Support
1077.04
Zydus Lifesciences Futures & Options
Zydus Lifesciences Option Chain
View Price, OI, Greeks & More...
30JUN26
1119.00
18.30 (1.66%)
28JUL26
1126.90
21.20 (1.92%)
25AUG26
1130.00
11.20 (1.00%)
ZYDUSLIFE|30JUN26 CE 1120.00
5.30
1.65 (45.21%)
ZYDUSLIFE|30JUN26 PE 1130.00
13.8
-18 (-56.6%)
Zydus Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-19 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Fund raising |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
Zydus Lifesciences News
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Zydus Lifesciences extended the closing date for its acquisition of Sterling Biotech's API business to September 30, 2026. This marks a second extension, indicating ongoing fulfillment of conditions precedent.
Jun 29 2026 14:36:17
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Joint Venture
Zydus Lifesciences Limited has formed a 50:50 joint venture, Zydus Sunshine Lifesciences, with Sunshine Healthcare Lanka Limited. The JV involves an investment of up to USD 5 million for Zydus's share and aims to establish a pharmaceutical manufacturing facility in Sri Lanka. The facility will produce pharmaceutical products to strengthen local production and reduce import dependence.
Jun 26 2026 07:55:33
Read More
Zydus Lifesciences Management
| Name | Position |
|---|---|
| Dhaval N Soni | Company Secretary & Compliance Officer |
| Pankaj R Patel | Chairman |
Zydus Lifesciences Similar Stocks
Divi's Laboratories Ltd.
6557.50
-156.00 (2.32%)
Torrent Pharmaceuticals Ltd.
4657.60
141.40 (3.13%)
Apollo Hospitals Enterprise Ltd.
8655.00
63.00 (0.73%)
Cipla Ltd.
1454.10
14.00 (0.97%)
Dr. Reddy's Laboratories Ltd.
1375.70
25.20 (1.87%)
Max Healthcare Institute Ltd.
1149.90
26.55 (2.36%)
Lupin Ltd.
2409.30
65.80 (2.81%)
Mankind Pharma Ltd.
2486.00
23.70 (0.96%)
Aurobindo Pharma Ltd.
1547.50
-7.70 (0.50%)
Lenskart Solutions Ltd.
505.85
-3.05 (0.60%)
Zydus Lifesciences FAQs
The Buying Price of Zydus Lifesciences share is 1121.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zydus Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zydus Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zydus Lifesciences shares is 21.8. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zydus Lifesciences shares is 4.22. Useful to assess the stock's value relative to its book value.
To assess Zydus Lifesciences’s valuation compare Sector P/E, P/B which are 69.63 & 3.12 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zydus Lifesciences is 112829.02 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zydus Lifesciences share price is 1126.00 & 835.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zydus Lifesciences belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
